Cargando…

Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients

BACKGROUND: Coronary artery calcification (CAC) is associated with cardiovascular mortality in end-stage renal disease (ESRD) patients. The present study aimed to identify modifiable risk factors for CAC progression in peritoneal dialysis (PD) patients. METHODS: Adult patients who received regular P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Da, Xie, Qionghong, Ge, Xiaolin, Yan, Huanqing, Tian, Jing, Kuang, Dingwei, Hao, Chuan-Ming, Zhu, Tongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506628/ https://www.ncbi.nlm.nih.gov/pubmed/26187601 http://dx.doi.org/10.1186/s12882-015-0103-8

Ejemplares similares

Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
por: Shang, Da, et al.
Publicado: (2017)

Prognostic values of left ventricular mass index progression in incident peritoneal dialysis patients : a prospective cohort study
por: Chen, Yun, et al.
Publicado: (2022)

Plasma fibrinogen: a driver of left ventricular remodeling in patients undergoing peritoneal dialysis and its related risk factors
por: Chen, Yun, et al.
Publicado: (2023)

The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patients
por: Niu, Qingyu, et al.
Publicado: (2020)

Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients
por: Imtiaz, Rameez, et al.
Publicado: (2017)

Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study
por: Gueiros, Ana Paula Santana, et al.
Publicado: (2019)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study
por: Yin, Xiaojing, et al.
Publicado: (2023)

Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline
por: Won, Ki-Bum, et al.
Publicado: (2020)

Progression of Aortic Arch Calcification Over 1 Year Is an Independent Predictor of Mortality in Incident Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2012)

Corrigendum: Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: a cross-sectional study
por: Yin, Xiaojing, et al.
Publicado: (2023)

Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations
por: New, Nicholas, et al.
Publicado: (2011)

Coronary artery calcification score and common iliac artery calcification score in non‐dialysis CKD patients
por: Mizuiri, Sonoo, et al.
Publicado: (2018)

Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis
por: Russo, Domenico, et al.
Publicado: (2011)

Vascular and Valvular Calcification in Chronic Peritoneal Dialysis Patients
por: Wang, Angela Yee-Moon
Publicado: (2011)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake
por: Fukuoka, Kazuhito, et al.
Publicado: (2017)

Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
por: Wish, Jay B.
Publicado: (2023)

Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia
por: Voelkl, Jakob, et al.
Publicado: (2019)

Vascular Calcification in an Adolescent Treated with Long-Term Peritoneal Dialysis
por: Ekim, Mesiha, et al.
Publicado: (2011)

The Prognostic Value of Abdominal Aortic Calcification in Peritoneal Dialysis Patients
por: Yoon, Hye Eun, et al.
Publicado: (2013)

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
por: Hutchison, Alastair J, et al.
Publicado: (2013)

Abdominal aortic calcification is superior to other arteries calcification in predicting the mortality in peritoneal dialysis patients – a 8 years cohort study
por: Niu, Qingyu, et al.
Publicado: (2019)

Long-Term Effects of Sevelamer on Vascular Calcification, Arterial Stiffness, and Calcification Propensity in Patients Receiving Peritoneal Dialysis: The Randomized Pilot SERENE (Sevelamer on Vascular Calcification, Arterial Stiffness) Trial
por: Wang, Angela Yee-Moon, et al.
Publicado: (2021)

Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis
por: Misian, Monika, et al.
Publicado: (2022)

Influence of sodium thiosulfate on coronary artery calcification of patients on dialysis: a meta-analysis
por: Huang, Chong, et al.
Publicado: (2023)

Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients
por: Liu, Xianhua, et al.
Publicado: (2018)

The Pharmacological Effect and Mechanism of Lanthanum Hydroxide on Vascular Calcification Caused by Chronic Renal Failure Hyperphosphatemia
por: Zhao, Lulu, et al.
Publicado: (2021)

Coronary (18)F-Fluoride Uptake and Progression of Coronary Artery Calcification
por: Doris, Mhairi K., et al.
Publicado: (2020)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

AGEs accumulation is related to muscle degeneration and vascular calcification in peritoneal dialysis patients
por: Fonseca, Laís de Faria, et al.
Publicado: (2021)

Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism
por: Ho, Tzung-Yo, et al.
Publicado: (2019)

Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients
por: Nishizawa, Yoko, et al.
Publicado: (2023)

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
por: Silva, Arnold L., et al.
Publicado: (2023)

Malnutrition leads to the progression of coronary artery calcification in hemodialysis patients
por: Okabe, Hiroki, et al.
Publicado: (2023)

Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients
por: Lee, Su Mi, et al.
Publicado: (2017)

Arterial “inflammaging” drives vascular calcification in children on dialysis
por: Sanchis, Pilar, et al.
Publicado: (2019)

Association between phase angle and coronary artery calcium score in patients on peritoneal dialysis
por: Reis, Fabricio Moreira, et al.
Publicado: (2022)

Vascular Calcifications Seen on Mammography: An Independent Factor Indicating Coronary Artery Disease
por: Oliveira, Evelling L. C., et al.
Publicado: (2009)

Radial augmentation index may be an effective predictor of vascular calcification in patients on peritoneal dialysis
por: Yang, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jd41spp1gsp8th3p4pch910hce